Veterinary Medicines

GALLIVAC IB 88, vaccin viu, liofilizat pentru suspensie pentru găini

Authorised
  • Avian infectious bronchitis virus, Live
Download as PDF

Product identification

Medicine name:
GALLIVAC IB 88, vaccin viu, liofilizat pentru suspensie pentru găini
Active substance:
  • Avian infectious bronchitis virus, Live
Target species:
  • Chicken (broiler)
Route of administration:
  • Nebulisation use
  • Ocular use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, Live
    4.00
    log 10 50% embryo infective dose
    /
    30.00
    microlitre(s)
Pharmaceutical form:
  • Nasal drops, lyophilisate and solvent for suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken (broiler)
      • Meat and offal
        0
        day
  • Ocular use
    • Chicken (broiler)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 120258
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 4/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."